FindTrial
Sign In

Evaluation of fatty liver using Attenuation imaging in candidates for living donor liver transplantation

Evaluation of fatty liver using Attenuation imaging in candidates for living donor liver transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0004486
Enrollment
120
Registered
2019-12-02
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: informed consent for the study who underwent living liver donor protocol MRI

Exclusion criteria

Exclusion criteria: time interval between MRI and ATI exceeds one month BMI equal to or greater than 30 unsuitable for informed consent any other condition that renders the subject unsuitable for study enrollment by the judgment of investigators

Design outcomes

Primary

MeasureTime frame
Accuracy of evaluation of fatty liver using ATI—

Secondary

MeasureTime frame
Accuracy of evaluation of fatty liver using NLV;Accuracy of evaluation of hepatic fibrosis using SWE—

Countries

Korea, Republic of

Contacts

Public ContactJae Seok Bae

Seoul National University Hospital

jaeseok.bae@gmail.com+82-2-2072-3107

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 10, 2026